No, you cannot pass HIV through sex if your viral load is undetectable. This principle, known as U=U (Undetectable = Untransmittable), is backed by decades of clinical evidence and endorsed by every major health organization worldwide. The caveat: your viral load must stay undetectable through consistent daily use of antiretroviral therapy (ART), and the protection applies specifically to sexual transmission.
What the Studies Actually Found
The evidence behind U=U comes from three landmark studies: HPTN 052, PARTNER, and Opposites Attract. Together, they tracked thousands of couples where one partner had HIV and the other did not, over years of condomless sex. The results were remarkably consistent: zero transmissions when the HIV-positive partner maintained viral suppression.
The PARTNER and PARTNER2 studies are particularly striking. Couples reported over 76,000 acts of condomless anal sex during the study period. While 15 new HIV infections occurred among participants during follow-up, genetic testing confirmed that none of these infections came from the study partner with HIV. Every new infection was acquired from someone outside the relationship. The resulting transmission rate between partners was zero.
The HPTN 052 trial followed more than 1,600 heterosexual couples over ten years and reached the same conclusion. Transmissions only occurred when the HIV-positive partner had just started treatment or when their medication had stopped working, meaning the virus was actively replicating. When treatment consistently suppressed the virus, no transmissions happened.
What “Undetectable” Means in Numbers
Viral suppression is defined as having fewer than 200 copies of HIV per milliliter of blood. An undetectable viral load means your levels are so low that standard lab tests can’t measure them at all, typically below 20 to 50 copies depending on the test used. Both thresholds fall within the range where U=U applies.
Reaching undetectable doesn’t happen overnight. Most guidelines recommend maintaining an undetectable viral load for at least six months before considering the virus untransmittable. After that initial period, routine viral load testing typically happens every three to six months. For people with a stable, consistently suppressed viral load and good adherence for over a year, testing can shift to every six months.
Viral Blips and What They Mean
Some people on ART experience occasional “blips,” brief, low-level spikes in viral load that resolve on their own. These are usually defined as a single measurable reading under 200 copies/mL that drops back to undetectable on the next test. In the PARTNER studies, participants experienced these small elevations during 4% to 6% of the total follow-up time, and still no linked transmissions occurred.
Blips typically reflect normal biological fluctuation or lab variability rather than treatment failure. They don’t mean your medication has stopped working. However, if your viral load rises to 200 copies/mL or above, guidelines recommend using additional protection (condoms or PrEP for your partner) until blood tests confirm you’re suppressed again. The tricky part is that a blip can only be confirmed in hindsight, once the next test shows you’ve returned to undetectable.
Where U=U Does Not Apply
The zero-transmission evidence is specific to sexual contact. For needle sharing and injection equipment, the picture is different. The CDC states that having an undetectable viral load “reduces” the chance of transmitting HIV through shared needles, syringes, or other injection equipment, but does not use the word “eliminates.” The studies that proved U=U for sexual transmission did not test injection-related routes, so the same guarantee cannot be made.
Breastfeeding is another area where undetectable does not mean zero risk. For mothers on ART with a sustained undetectable viral load during and after pregnancy, the risk of passing HIV to an infant through breast milk is less than 1%, but it is not zero. This is a meaningful reduction, but it’s a conversation to have with a provider well before delivery, ideally before or early in pregnancy, so feeding options can be weighed carefully.
What About Other STIs?
Having another sexually transmitted infection can cause low-level shedding of HIV in genital secretions, even in people on effective treatment. This was a concern for years, but the research has been reassuring. The viral particles shed during an STI in someone on suppressive ART do not appear to be capable of replicating or causing infection. The large transmission studies included couples where STIs were present, and the result held: zero linked transmissions. ART effectively interrupts HIV transmission even when other STIs are in the picture.
Why Consistency Matters
U=U depends entirely on staying on treatment. Missing doses, running out of medication, or stopping ART allows the virus to rebound, sometimes within days. Once viral load climbs above 200 copies/mL, the protection disappears and transmission becomes possible again. The studies that proved U=U were clear on this: every transmission that occurred happened when the partner with HIV was not fully suppressed.
This makes adherence the foundation of U=U. Taking ART daily as prescribed, keeping follow-up appointments, and getting regular viral load tests are what maintain the protection. For people who have difficulty with daily pills, longer-acting injectable treatments given every one to two months offer an alternative that removes the daily adherence barrier while achieving the same viral suppression.